Get the Stockscreener App
0.00
100.00%
-17.11
Veraxa Biotech Ag stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Voyager Acquisition Corp is a blank check company.
See More
Previous Close:
$17.11
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$541.25M
Revenue:
-
Net Income/Loss:
$6.74M
P/E Ratio:
0.00
EPS:
0.2142
Net Cash Flow:
$-412.70K
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$18.16
Veraxa Biotech Ag Stock (VACH) Company Profile
Name
Veraxa Biotech Ag
Sector
Industry
Phone
03477204333
Address
C/O WINSTON & STRAWN LLP, HOUSTON
Compare VACH vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VACH
Veraxa Biotech Ag
|
0.00 | 541.25M | 0 | 6.74M | -412.70K | 0.2142 |
LION
Lionsgate Studios Corp
|
15.00 | 4.36B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.72 | 1.98B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
21.51 | 1.03B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.08 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
BCSS
Bain Capital Gss Investment Corp
|
10.27 | 599.77M | 0 | 8.29M | -686.50K | 0.142 |
Veraxa Biotech Ag Stock (VACH) Latest News
VRXA|Veraxa Biotech AG Ord Shs|Price:3.000|Chg%:-1.14 - TradingKey
VRXA|Veraxa Biotech AG Ord Shs|Price:3.440|Chg%:-0.70 - TradingKey
VERAXA Biotech (VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention - NewMediaWire
VERAXA Biotech Seeks Partners for BiTAC Cancer Platforms at BIO International Convention - MEXC
VERAXA Biotech to Showcase BiTAC Cancer Platforms at BIO International Convention - citybuzz -
VERAXA Biotech (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention - The Globe and Mail
VERAXA Biotech (VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform - NewMediaWire
Appleby Advises Voyager Acquisition Corp. In Its Business Combination With Veraxa Biotech AG - Mondaq
symbol__ Stock Quote Price and Forecast - CNN
Veraxa Biotech reports data on BiTAC-ADC cancer platform By Investing.com - Investing.com Canada
VERAXA Biotech (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform - USA Today
VRXA SEC FilingsVeraxa Biotech AG 10-K, 10-Q, 8-K Forms - Stock Titan
VERAXA Biotech Reports Proof-of-Concept Data for Tumor-Restricted BiTAC-ADC Cancer Therapy Platform - citybuzz -
Veraxa Biotech reports data on BiTAC-ADC cancer platform - Investing.com
VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 - Yahoo Finance
VERAXA’s cancer therapy platform clears lab test, seeks partners - Stock Titan
VERAXA Biotech AG: Advancing Next-Generation Antibody-Based Cancer Therapies - citybuzz -
Why VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’ - The Globe and Mail
Why VERAXA Biotech AG (VRXA) Is 'One to Watch' - Yahoo Finance
Veraxa Biotech: Post-Merger Valuation Does Not Match The Risk - Seeking Alpha
[20-F] Veraxa Biotech Holding AG Files Annual Report (Foreign Issuer) | VRXA SEC FilingForm 20-F - Stock Titan
European Molecular Biology Laboratory discloses 16.2% VRXA stake after SPAC merger - Stock Titan
Veraxa Biotech (VRXA) holder discloses 18% stake and VWAP earnout - Stock Titan
VERAXA Biotech AG’s Diversified Oncology Pipeline Positions It as a Company to Watch - citybuzz -
VRXA - Finviz
Veraxa Biotech Holding (VRXA) Stock Analysis Report | Financials & Insights - Benzinga
Veraxa Biotech Holding (VRXAW) Stock Analysis Report | Financials & Insights - Benzinga
Xlife Sciences discloses 16.3% Veraxa (VRXA) stake after business combination - Stock Titan
Major Veraxa (VRXA) shareholder reports 15.9% stake and potential 5M earnout shares - Stock Titan
Number of employees of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech AG Financial Statements – NASDAQ:VRXAW - TradingView
Current ratio of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
All News for VRXA : Veraxa Biotech AG - Zacks Investment Research
Veraxa Biotech AG Earnings and Revenue – NASDAQ:VRXA - TradingView
Net debt of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Basic earnings per share (basic EPS) of Veraxa Biotech AG – BOATS:VRXA - TradingView
Operating expenses (excl. COGS) of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Debt to assets ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Price to book ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
EBITDA per share of Veraxa Biotech AG – BOATS:VRXAW - TradingView
VERAXA Biotech (NASDAQ: VRXA) Is ‘One to Watch’ - The Globe and Mail
Operating cash flow per share of Veraxa Biotech AG – BOATS:VRXA - TradingView
Return on equity % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Return on invested capital % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Total common shares outstanding of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Total equity of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Gross margin % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Net margin % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Price to sales ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Net debt of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Total liabilities & shareholders' equities of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Veraxa Biotech Ag Stock (VACH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):